ARG
GSK icon

Advisory Resource Group’s GSK GSK Stock Holding History

Advisory Resource Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,549
Closed -$309K – 164
2024
Q3 		$309K Sell
7,549
-163
-2% -$6.67K 0.07% 135
2024
Q2 		$297K Buy
7,712
+247
+3% +$10.4K 0.07% 132
2024
Q1 		$320K Buy
+7,465
New +$308K 0.07% 134

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisory Resource Group's GSK Position: Q4 2024 in Review

Advisory Resource Group sold out of GSK (GSK) in Q4 2024, closing a stake of 7,549 shares — an estimated $309K sold.

Advisory Resource Group first reported a position in GSK in Q1 2024 and held it in 3 quarters. The position peaked at $320K in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Advisory Resource Group reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Advisory Resource Group sold 7,549 GSK shares in Q4 2024, an estimated $309K.
  • Advisory Resource Group first reported a position in GSK in Q1 2024 and held it in 3 quarters.
  • Advisory Resource Group's GSK position peaked at $320K in Q1 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Advisory Resource Group's 13F filing for Q4 2024, filed 28 Jan 2025.